期刊文献+

奥拉西坦的合成工艺改进

Improvement of Synthesis Technics of Oxiracetam
下载PDF
导出
摘要 奥拉西坦为吡咯烷酮类衍生物,用于脑损伤及引起的神经功能缺失、记忆与智能障碍的治疗。针对奥拉西坦合成工艺存在合成路线长、废固较多、操作复杂、产品不易提纯等问题,提出了一种合成奥拉西坦的改进方法,即以4-氯乙酰乙酸乙酯和甘氨酰胺为原料合成奥拉西坦,研究了催化剂、反应溶剂、反应时间对反应体系的影响,找到了最佳优化条件:环合反应p H值为10.5~11.0,乙醇水溶液比例为1∶8,甘氨酰胺配比为1∶1.0,环合反应溶剂配比为1∶25,环合反应温度为77~78℃,催化剂用量为1∶100,反应时间为12~14 h。该方法具有原料易得,制备过程简单、产率较高,适宜工业生产等优点。 Oxiracetam is a kind of pyrrolidone derivatives that used for the treatment of brain damage and neurological deficit, impediment of anamnesis and aptitude that caused by brain damage. Aiming at the problems that exist in the synthesis technics of oxiracetam which are too many steps in the synthesis process, too much solid waste, complex operation, and products difficult to purification etc., a new improved method for the synthesis of oxiracetam is proposed,that is ethyl 4- chloroacetoacetate and glycinamide as the raw materials to synthesize oxiracetam. The influences of catalyst,reaction solvent, reaction time on the reaction system were studied. The found best optimum conditions are cyclization reaction p H is 10.5~11.0, the proportion of ethanol water is 1∶8, ratio of glycinamide is 1∶1.0, ratio of the cyclization reaction solvent is 1∶25, cyclization reaction temperature is 77~78℃, the amount of catalyst is 1∶100, and the reaction time is 12 ~ 14 h. The method has the advantages such as raw materials are easy to get, the manufacturing process is simple, high yield, suitable for industrial production and so on.
出处 《煤炭与化工》 CAS 2015年第7期80-82,共3页 Coal and Chemical Industry
关键词 奥拉西坦 甘氨酰胺盐酸盐 合成工艺 oxiracetam glycinamide hydrochloride synthesis technic
  • 相关文献

参考文献12

二级参考文献24

  • 1郑辉,刘娟,施巧月,梅怡嘉.奥拉西坦中间体的合成研究[J].化工中间体,2012,8(1):31-33. 被引量:3
  • 2王淑贞,迟兆富,麻琳,张镛,狄晴,韩钊,于浩,韩婷.注射用奥拉西坦治疗器质性脑综合征随机双盲对照多中心研究[J].中国新药与临床杂志,2007,26(4):267-271. 被引量:13
  • 3汪以性主编.新编实用药物学[M].北京:科学出版社,2000.160.
  • 4王淑贞,迟兆富,郭洪志,张镛,罗本燕,裴海涛,邢成名,孙瑞元.奥拉西坦治疗脑器质性综合征随机双盲对照多中心研究[J].中国药学杂志,2007,42(15):1194-1196. 被引量:13
  • 5Saletu B,Linzmayer L,Grünberger J,et al.Double-blind,placebo-controlled,clinical,psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life[J].Neuropsychobiology,1985,13(1-2):44-52.
  • 6Kometani M,Okada M,Takemori E,et al.Effect of oxiracetam on cerebrovascular impairment in rats[J].Arzneimittelforschung,1991,41(7):684-689.
  • 7Ttil TM,Menon GN,Bozak M,et al.The effects of oxiracetam(ISF-2522)in patients with organic brain syndrome a double controlled study with piracetam[J].Drug Dev Res,1982,2(5):447-447.
  • 8Baumel B,Eisner L,Karukin M,et al.Oxiracetam in the treatment of multi-infarct dementia[J].Prog Neuropsychopharmacol Biol Psychiatry,1989,13(5):673-682.
  • 9Pinza Mario,Pfeiffer Ugo claudio.Pyrrolidinone derivatives[P].EP Pat:156655,19851002.
  • 10Irwchijimo,shinozbn.Process for producing Oxiracetam useful for improving brain metabolism[P].EP Pat:223328,19870527.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部